MedPath

Comparative study of the effect of capsules Ginger-Lavender, Ginger with Mefenamic Acid on the severity of primary dysmenorrhea

Phase 3
Conditions
primary dysmenorrhea.
Primary dysmenorrhoea
N94.4
Registration Number
IRCT20200525047565N2
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
90
Inclusion Criteria

1)Be 18 to 30 years old and single.
2)Experience menstrual pain in the first 3 days of bleeding for 3 consecutive periods in the last 6 months
3)People with primary dysmenorrhea whose pain intensity is moderate to severe according to McGill's pain ruler
4)Not known to be a person with a chronic illness (diabetes, high blood pressure, cardiovascular, infectious, liver, and epilepsy)
5)Do not have a specific gynecological disease that interferes with the study process
6)Have regular cycles with intervals of 21 to 38 days and the duration of menstruation is 3-7 days
7)Their body mass index is in the normal range of 19.8 to 26
8)According to the person, there are no symptoms such as burning, itching or abnormal discharge during the study.
9)Do not take any medications or supplements.
10)No herbal medicine has been used for 3 months before the intervention.01
11)Stressful factors such as parental separation, death of first-degree relatives, etc. should not be present in the last six months

Exclusion Criteria

1)Dissatisfaction or obedience of the person to continue participating in the study
2)Lack of proper use of medication or mefenamic acid
3)Take any herbal medicine while studying

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of primary dysmenorrhea. Timepoint: End of the third day of the cycle before the intervention, end of the third day of the first cycle and second cycle after the intervention. Method of measurement: Visual analog scale.
Secondary Outcome Measures
NameTimeMethod
Systematic symptoms. Timepoint: End of the third day of the cycle before the intervention, end of the third day of the first cycle and second cycle after the intervention. Method of measurement: Verbal rating scale.
© Copyright 2025. All Rights Reserved by MedPath